The role of panels of experts from outside government in the FDA's day-to-day work derives from the Drug Efficacy Study of the 1960s, which addressed many concerns that continue to shape discussions of pharmaceutical regulation.
No takes yet. Share an insight, caveat, or question.
Jason L. Schwartz (2016) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: